SCHEMBL21312486

SCHEMBL21312486

CC1c2ccccc2C(=O)OC2CCCCC21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 4/20 0.40
PRSS1 P07477 4/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40
RECQL P46063 1/20 0.40
PARP1 P09874 1/20 0.36
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
NPC1 O15118 1/20 0.34
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22879371 0.81 LMNA (0.40) F2PRSS1ALDH1A1LMNARECQL
SCHEMBL24119479 0.81 LMNA (0.38) F2PRSS1ALDH1A1LMNARECQL
SCHEMBL21400399 0.79 ABCB1 (0.44) F2PRSS1
SCHEMBL16257250 0.77 PARP1 (0.50) ALDH1A1LMNARECQLPARP1MEN1
SCHEMBL15256958 0.75 LMNA (0.43) ALDH1A1LMNARECQLPARP1MEN1
SCHEMBL21312462 0.73 PARP1 (0.36) ALDH1A1LMNAPARP1MAPTHPGD
SCHEMBL15256933 0.72 ALDH1A1 (0.50) ALDH1A1LMNAMEN1CYP1A2CYP3A4
SCHEMBL21311821 0.72 PARP1 (0.42) ALDH1A1LMNARECQLPARP1MEN1
SCHEMBL21311830 0.71 CYP2A6 (0.35) ALDH1A1LMNAPARP1MAPTHPGD
SCHEMBL5529318 0.70 PRSS1 (0.44) F2PRSS1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019161781-A1 RECEPTOR ANTAGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USAGE THEREOF 北京泰德制药股份有限公司 2019-08-29 WO disclosed